Clinical and Diagnostic Laboratory Immunology, November 1998, p. 808-813, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Institute of Immunology and Transfusion
Medicine,
Received 4 May 1998/Returned for modification 7 June 1998/Accepted 18 September 1998
Despite recent advances in DNA-based genotyping, the
microcytotoxicity test is still broadly used for the determination of human leukocyte class I antigens in patients as well as organ donors
and also for the detection of HLA antibodies. Excellent purity and
viability of peripheral blood mononuclear cells (PBMC) are essential
for reliable HLA typing results. Background staining and cell loss can
contribute to impaired typing results or even cause misinterpretations.
A novel isolation procedure using cell preparation tubes (CPT) with
prefilled Ficoll was compared with the standard Ficoll gradient. We
determined the recovery, purity, and viability of the PBMC after
several periods of storage. Finally, the isolated cells were used for
HLA class I typing, and background reactivities were scored. By using
the CPT method, the recovery of PBMC was significantly higher than
recovery with the standard technique (P
0.001). Contamination by granulocytes increased considerably
during the storage time for the standard protocol, whereas purity
remained stable when CPT were used (P
0.001). With both methods, lymphocyte viability declined markedly over time. We
found significantly more dead cells by using the CPT methods. Due to
high background scores, HLA typing was impossible after 48 h. The
isolation of PBMC by the CPT method resulted in a higher yield and
improved purity compared to those obtained with the standard gradient
technique. The decreasing viability after 48 h limits the use of
both methods for HLA typing and HLA antibody screening.
*
Corresponding author. Mailing address: University of
Luebeck, Institute of Immunology and Transfusion Medicine, Ratzeburger Allee 160, 23538 Luebeck, Germany. Phone: 49-451-5002841. Fax: 49-451-5002857. E-mail: schlenke{at}immu.mu-luebeck.de.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |